Skip to main content
OpenTrials
Completed

NCT Number: NCT06274736

Safety and Performance of Motiva® Sizers

The Motiva® Sizer clinical study is a four-year, multicenter, post-marketing, and cohort study, designed to confirm the safety and performance of Motiva® Sizer in breast augmentation or reconstruction procedures.

The research will include 133 women, divided into two groups (56 with sizers and 78 without sizers). The Motiva® Sizer exposed group will consist of women who will undergo breast augmentation or reconstruction surgery with the use of Motiva® Sizer during the procedure, and a non-exposed group will consist of women who will undergo breast augmentation or reconstruction surgery without the use of Motiva® Sizer. This study will be conducted in Costa Rica.

The main goal is to evaluate the safety and the performance of the Motiva® Sizer. To this end, the results of both groups will be compared in terms of surgical complications, surgeon's, and participant's satisfaction level as well as reoperation rates.

After the augmentation or reconstruction surgery, participants will be scheduled for the following follow-up visits, (1) between 3 and 7 postoperative days, (2) between 3 and 6 postoperative weeks, (3) at 3 and (4) 6 postoperative months, and (5) one year. In case any participant has an adverse event due to the procedure, and if required by the physician, an additional visit will be made to assess her, and this information as well as that of the scheduled visits should be recorded in the electronic data collection notebook.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Establishment Labs

Coyol, Alajuela Province, 20102, Costa Rica

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female, 18 years of age or older.
  • The participant will be undergoing a breast augmentation or reconstruction procedure.
  • To possess enough and adequate tissue to cover the implants.
  • Willingness to comply with all study requirements, including signing the informed consent document and agreeing to attend all required follow-up visits.

Exclusion criteria

  • Existing rib injuries.
  • Inadequate or unsuitable tissue for augmentation or reconstruction surgery at the physician's discretion.
  • History of abscesses or infections in the breast area.
  • Current pregnancy or breastfeeding, or full-term pregnancy or breastfeeding in the six months prior to enrollment.
  • History of sensitivity to silicone.
  • Any medical condition, such as underweight or obesity, diabetes, autoimmune disease or severe chronic pulmonary or cardiovascular disease, psychological/psychiatric disorders that may result in unduly high surgical risk and/or significant postoperative complications.
  • Active or recurrent breast cancer.
  • Consumption of any medication that, in the investigator's experience, may pose an increased risk of complications or interfere with wound healing ability, such as corticosteroid therapy or blood clotting medication (e.g., concomitant treatment with warfarin).
  • Not living in the country where the procedure was performed , which prevents him/her from attending follow-up visits .

Treatment and study plan

Motiva Sizer

Device

No intervention will be made,

Primary outcomes

  1. Motiva Sizers Safety (complications)

    Time frame: 1 year

    Cumulative incidence of complications between participants in whom Motiva® Sizer was used during breast augmentation or reconstruction surgery, and participants in whom intraoperative breast sizers were not used during breast augmentation or reconstruction surgery

  2. Motiva Sizers Performance (satisfaction)

    Time frame: 1 year

    Percentage of participants and surgeons who are satisfied or very satisfied with surgery´s results with and without Motiva® Sizer. (based on 5-point Likert scale, in which 1 is Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4 Satisfied, 5 Very satisfied) measured at 1st, 3rd, 6th months after surgery and 1st year.

Secondary outcomes

  1. Motiva Sizers Safety (reoperations)

    Time frame: 1 year

    Re-operation rates between participants in whom Motiva® Sizers were used during augmentation or breast reconstruction surgery and participants in whom Motiva® Sizers were not used during augmentation or breast reconstruction surgery.

Sponsors and collaborators

Lead sponsor

Establishment Labs

Industry

Registry information

Official study title

Post-marketing Cohort Study to Confirm the Safety and Performance of Motiva® Sizers in Breast Augmentation and Reconstruction Procedures

Important dates

Study start
2023
Primary completion
2023
Study completion
2026
First posted
Feb 23, 2024
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.